Studies on antitumor-active 2,3-dioxopiperazine derivatives. I. Degradation products of 1-(2-chloroethyl)-3-(4-substituted-2,3-dioxo-1-piperazinyl)-alkyl-1-nitrosourea  in aqueous solution.
D000818:Animals; D000970:Antineoplastic Agents / Q000032:analysis* / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004355:Drug Stability; D005260:Female; D051379:Mice; D009607:Nitrosourea Compounds / Q000032:analysis / Q000494:pharmacology; D010879:Piperazines / Q000032:analysis* / Q000494:pharmacology; D012996:Solutions
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D010879:Piperazines; D012996:Solutions; C032009:1-(2-(4-ethyl-2,3-dioxo-1-piperaziny)ethyl)-3-methylurea; C032010:1,3-bis(4-(4-ethyl-2,3-dioxo-1-piperazinyl)butyl)urea